The Vietnamese government is looking to boost its share of the world's clinical research market, signing a deal with CRO giant Quintiles ($Q) to get the ball rolling.
Under a two-year agreement, the world's largest CRO will help Vietnam's Administration of Science, Technology and Training (ASTT) set up training programs for investigators, streamline regulatory processes and improve trial management across the country, expanding upon a years-long relationship, Quintiles said.
The goal is to establish Vietnam as a go-to center for clinical research in Asia, developing new and better therapies for the tropical and infectious diseases that afflict the region, ASTT Director Nguyen Cong Khan said.
"Quintiles knows how to conduct clinical research to global standards and its experts understand Asia and Vietnam," Khan said in a statement. "By sharing their knowledge and insights, Quintiles can help us develop and execute a long-term plan for improving the quality, scope and breadth of clinical research in Vietnam."
Quintiles has been working to expand Vietnamese investigator training and site development since expanding into the country in 2005, Regional Director Ross Horsburgh said, and the deal with Vietnam follows similar arrangements with up-and-coming countries around the world.
- read the announcement